SCHEMBL30867883

SCHEMBL30867883

COC1(c2nccc(C)c2C2CCNC(=O)C2)COC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
ALDH2 P05091 1/20 0.33
MAP3K12 Q12852 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867882 0.84 HTR1A (0.36) TLR8TLR7
SCHEMBL30867708 0.81 PLG (0.32)
SCHEMBL30867762 0.74 PDE4A (0.38)
SCHEMBL30867816 0.74 DDB1 (0.33)
SCHEMBL30867858 0.74 HTR2A (0.31)
SCHEMBL38654423 0.74 HTR2A (0.31)
SCHEMBL30867920 0.72 GPR119 (0.43)
Hydrochloric Acid SCHEMBL30867700 0.72
SCHEMBL38653881 0.70 RAF1 (0.32) TLR8TLR7
SCHEMBL30867758 0.70 GPR119 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598917-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
EP-4598915-A2 TETHERED HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
WO-2024076674-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed
WO-2024076670-A2 TETHERED HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed